Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials.
Bootman JL. Bootman JL. J Am Acad Dermatol. 1998 May;38(5 Pt 3):S69-72. doi: 10.1016/s0190-9622(98)70488-8. J Am Acad Dermatol. 1998. PMID: 9594941 Review.
Pharmacoeconomics: historical perspective.
Bootman JL, McGhan WF, Townsend RJ. Bootman JL, et al. Ann Pharmacother. 2006 Mar;40(3):518-9. doi: 10.1345/aph.1G390. Epub 2006 Feb 14. Ann Pharmacother. 2006. PMID: 16478813 No abstract available.
Drug-related morbidity and mortality: an economic and clinical perspective.
Bootman JL. Bootman JL. Manag Care. 2002 Feb;11(2 Suppl):12-5. Manag Care. 2002. PMID: 11907995 No abstract available.
Clinical and economic effects of suboptimally controlled asthma.
Bootman JL, Crown WH, Luskin AT. Bootman JL, et al. Manag Care Interface. 2004 Jan;17(1):31-6. Manag Care Interface. 2004. PMID: 15035598
Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review.
Gharaibeh M, Bootman JL, McBride A, Martin J, Abraham I. Gharaibeh M, et al. Among authors: bootman jl. Pharmacoeconomics. 2017 Jan;35(1):83-95. doi: 10.1007/s40273-016-0452-6. Pharmacoeconomics. 2017. PMID: 27637757 Review.
Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer.
Gharaibeh M, McBride A, Bootman JL, Patel H, Abraham I. Gharaibeh M, et al. Among authors: bootman jl. J Med Econ. 2017 Apr;20(4):345-352. doi: 10.1080/13696998.2016.1269015. Epub 2016 Dec 21. J Med Econ. 2017. PMID: 27919186
Costs, innovation and efficiency in anti-infective therapy.
Bootman JL, Milne RJ. Bootman JL, et al. Pharmacoeconomics. 1996;9 Suppl 1:31-9. doi: 10.2165/00019053-199600091-00007. Pharmacoeconomics. 1996. PMID: 10160114 Review.
The economics of multiple sclerosis. Distribution of costs and relationship to disease severity.
Grudzinski AN, Hakim Z, Cox ER, Bootman JL. Grudzinski AN, et al. Among authors: bootman jl. Pharmacoeconomics. 1999 Mar;15(3):229-40. doi: 10.2165/00019053-199915030-00003. Pharmacoeconomics. 1999. PMID: 10537431 Review.
Cost-effectiveness of consultant pharmacists in managing drug-related morbidity and mortality at nursing facilities.
Harrison DL, Bootman JL, Cox ER. Harrison DL, et al. Among authors: bootman jl. Am J Health Syst Pharm. 1998 Aug 1;55(15):1588-94. doi: 10.1093/ajhp/55.15.1588. Am J Health Syst Pharm. 1998. PMID: 9706185 No abstract available.
The health care cost of drug-related morbidity and mortality in nursing facilities.
Bootman JL, Harrison DL, Cox E. Bootman JL, et al. Arch Intern Med. 1997 Oct 13;157(18):2089-96. Arch Intern Med. 1997. PMID: 9382665
82 results
Jump to page
Feedback